Rhenman & Partners Asset Management Ab Baxter International Inc Transaction History

Rhenman & Partners Asset Management Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$73.77 - $83.61 $8.11 Million - $9.2 Million	-110,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$80.5 - $88.01 $6.44 Million - $7.04 Million	-80,000 Reduced 42.11%	110,000 $8.86 Million
Q1 2021 May 14, 2021	SELL	$76.38 - $86.03 $1.15 Million - $1.29 Million	-15,000 Reduced 7.32%	190,000 $16 Million
Q4 2020 Jan 19, 2021	BUY	$75.39 - $82.36 $3.77 Million - $4.12 Million	50,000 Added 32.26%	205,000 $16.4 Million
Q3 2020 Oct 13, 2020	BUY	$78.33 - $90.73 $4.7 Million - $5.44 Million	60,000 Added 63.16%	155,000 $12.5 Million

Q2 2020 Jul 16, 2020	BUY	$78.66 - $94.14 $7.47 Million - $8.94 Million	95,000 New	95,000 $8.18 Million

1,024

442M

4.22M

2.52M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.